Victoria Confirms 6 Liver Toxicity Cases Linked to Unapproved Retatrutide Peptide

2 articles · Updated · The Australian Financial Review · Jun 25

Six people in Victoria developed acute liver toxicity this year after taking an unapproved peptide labelled as Retatrutide, the state health department confirmed last week.
Doctors and social media influencers have promoted peptides heavily, but the report says evidence that unapproved versions work is virtually non-existent.
Similar cases are believed to have been reported elsewhere in Australia, widening concern beyond Victoria and pointing to broader risks from unapproved peptide use.

Sources

After severe poisonings in Australia, why is the U.S. considering making these risky peptides more accessible?

What hidden dangers lurk inside the 'research only' peptides promoted by online influencers?